Note to users. If you're seeing this message, it means that your browser cannot find this page's style/presentation instructions -- or possibly that you are using a browser that does not support current Web standards. Find out more about why this message is appearing, and what you can do to make your experience of our site the best it can be.
Submitted on November 21, 2003
Accepted on April 13, 2004
S-Nitrosylation of Parkin Regulates Ubiquitination and Compromises Parkin's Protective Function
Kenny K. K. Chung 1,Ted M. Dawson 2*,Bobby Thomas 3,Xiaojie Li 3,Olga Pletnikova 4,Juan C. Troncoso 5,Laura Marsh 6,Valina L. Dawson 7
1 Institute for Cell Engineering, Dept. of Neurobiology, Suite 731, Johns Hopkins University School of Medicine, 733 North Broadway Street, Baltimore, MD 21205, USA. 2 Institute for Cell Engineering, Departments of Neurology, Neuroscience, Johns Hopkins University School of Medicine, Baltimore, MD 21205, USA. 3 Institute for Cell Engineering, Dept. of Neurology, Suite 731, Johns Hopkins University School of Medicine, 733 North Broadway Street, Baltimore, MD 21205, USA. 4 Department of Pathology, Johns Hopkins University School of Medicine, 600 North Wolfe Street, Baltimore, MD 21205, USA. 5 Department of Neurology and Pathology, Johns Hopkins University School of Medicine, 600 North Wolfe Street, Baltimore, MD 21205, USA. 6 Department of Neurology and Psychology, Johns Hopkins University School of Medicine, 600 North Wolfe Street, Baltimore, MD 21205, USA. 7 Institute for Cell Engineering, Departments of Neurology, Neuroscience, and Physiology, Johns Hopkins University School of Medicine, Baltimore, MD 21205, USA.
* To whom correspondence should be addressed.
Ted M. Dawson , E-mail: tdawson{at}jhmi.edu
Parkin is an E3 ubiquitin ligase, which is involved in the ubiquitinationof proteins that are important in the survival of dopamine neuronsin Parkinson's disease (PD). Here we show that parkin is S-nitrosylatedin vitro, and in vivo in the MPTP animal model of PD and inbrains of patients with PD and diffuse Lewy body disease. Moreover,S-nitrosylation inhibits parkin's ubiquitin E3-ligase activityand its protective function. The inhibition of parkin's ubiquitinE3-ligase activity by S-nitrosylation could contribute to thedegenerative process in these disorders by impairing the ubiquitinationof parkin substrates and parkin's protective function.
The editors suggest the following Related Resources on Science sites:
In Science Magazine
TECHNICAL COMMENTS
Stuart A. Lipton, Tomohiro Nakamura, Dongdong Yao, Zhong-Qing Shi, Takashi Uehara, and Zezong Gu (24 June 2005) Science308 (5730), 1870b.
[DOI: 10.1126/science.1110135] |Full Text »|PDF »
TECHNICAL COMMENTS
Kenny K. K. Chung, Valina L. Dawson, and Ted M. Dawson (24 June 2005) Science308 (5730), 1870c.
[DOI: 10.1126/science.1110353] |Full Text »|PDF »
LETTERS
Jack R. Lancaster, Jr.;, Kenny K. K. Chung, Valina L. Dawson, and Ted M. Dawson (25 June 2004) Science304 (5679), 1905a.
[DOI: 10.1126/science.304.5679.1905a] |Full Text »|PDF »
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES:
Identification of a Novel Zn2+-binding Domain in the Autosomal Recessive Juvenile Parkinson-related E3 Ligase Parkin.
V. A. Hristova, S. A. Beasley, R. J. Rylett, and G. S. Shaw (2009)
J. Biol. Chem.
284, 14978-14986
|Abstract »|Full Text »|PDF »
The F-box Protein {beta}-TrCp1/Fbw1a Interacts with p300 to Enhance {beta}-Catenin Transcriptional Activity.
A. K. Mustafa, M. M. Gadalla, and S. H. Snyder (2009)
Science Signaling
2, re2
|Abstract »|Full Text »|PDF »
S-nitrosylation of XIAP compromises neuronal survival in Parkinson's disease.
A. H. K. Tsang, Y.-I. Lee, H. S. Ko, J. M. Savitt, O. Pletnikova, J. C. Troncoso, V. L. Dawson, T. M. Dawson, and K. K. K. Chung (2009)
PNAS
106, 4900-4905
|Abstract »|Full Text »|PDF »
E. Rubio de la Torre, B. Luzon-Toro, I. Forte-Lago, A. Minguez-Castellanos, I. Ferrer, and S. Hilfiker (2009)
Hum. Mol. Genet.
18, 809-823
|Abstract »|Full Text »|PDF »
Depletion of the ATPase NSF from Golgi membranes with hypo-S-nitrosylation of vasorelevant proteins in endothelial cells exposed to monocrotaline pyrrole.
S. Mukhopadhyay, J. Lee, and P. B. Sehgal (2008)
Am J Physiol Heart Circ Physiol
295, H1943-H1955
|Abstract »|Full Text »|PDF »
Aberrant Folding of Pathogenic Parkin Mutants: AGGREGATION VERSUS DEGRADATION.
J. S. Schlehe, A. K. Lutz, A. Pilsl, K. Lammermann, K. Grgur, I. H. Henn, J. Tatzelt, and K. F. Winklhofer (2008)
J. Biol. Chem.
283, 13771-13779
|Abstract »|Full Text »|PDF »
S-nitrosylation of peroxiredoxin 2 promotes oxidative stress-induced neuronal cell death in Parkinson's disease.
J. Fang, T. Nakamura, D.-H. Cho, Z. Gu, and S. A. Lipton (2007)
PNAS
104, 18742-18747
|Abstract »|Full Text »|PDF »
A cell biological perspective on mitochondrial dysfunction in Parkinson disease and other neurodegenerative diseases.
W. Mandemakers, V. A. Morais, and B. De Strooper (2007)
J. Cell Sci.
120, 1707-1716
|Abstract »|Full Text »|PDF »
Assessment and Application of the Biotin Switch Technique for Examining Protein S-Nitrosylation under Conditions of Pharmacologically Induced Oxidative Stress.
M. T. Forrester, M. W. Foster, and J. S. Stamler (2007)
J. Biol. Chem.
282, 13977-13983
|Abstract »|Full Text »|PDF »
Mitochondrial nitric oxide in the signaling of cell integrated responses.
M. C. Carreras and J. J. Poderoso (2007)
Am J Physiol Cell Physiol
292, C1569-C1580
|Abstract »|Full Text »|PDF »
Phosphorylation of Parkin by the Cyclin-dependent Kinase 5 at the Linker Region Modulates Its Ubiquitin-Ligase Activity and Aggregation.
E. Avraham, R. Rott, E. Liani, R. Szargel, and S. Engelender (2007)
J. Biol. Chem.
282, 12842-12850
|Abstract »|Full Text »|PDF »
Biphasic Coupling of Neuronal Nitric Oxide Synthase Phosphorylation to the NMDA Receptor Regulates AMPA Receptor Trafficking and Neuronal Cell Death.
G. A. Rameau, D. S. Tukey, E. D. Garcin-Hosfield, R. F. Titcombe, C. Misra, L. Khatri, E. D. Getzoff, and E. B. Ziff (2007)
J. Neurosci.
27, 3445-3455
|Abstract »|Full Text »|PDF »
Emerging Roles for Ubiquitin and Protein Degradation in Neuronal Function.
A Classification Scheme for Redox-Based Modifications of Proteins.
M. T. Forrester and J. S. Stamler (2007)
Am. J. Respir. Cell Mol. Biol.
36, 135-137
|Full Text »|PDF »
A Drosophila Model of Mutant Human Parkin-Induced Toxicity Demonstrates Selective Loss of Dopaminergic Neurons and Dependence on Cellular Dopamine.
T.-K. Sang, H.-Y. Chang, G. M. Lawless, A. Ratnaparkhi, L. Mee, L. C. Ackerson, N. T. Maidment, D. E. Krantz, and G. R. Jackson (2007)
J. Neurosci.
27, 981-992
|Abstract »|Full Text »|PDF »
S-Nitrosylation of Bcl-2 Inhibits Its Ubiquitin-Proteasomal Degradation: A NOVEL ANTIAPOPTOTIC MECHANISM THAT SUPPRESSES APOPTOSIS.
N. Azad, V. Vallyathan, L. Wang, V. Tantishaiyakul, C. Stehlik, S. S. Leonard, and Y. Rojanasakul (2006)
J. Biol. Chem.
281, 34124-34134
|Abstract »|Full Text »|PDF »
Identification of Far Upstream Element-binding Protein-1 as an Authentic Parkin Substrate.
H. S. Ko, S. W. Kim, S. R. Sriram, V. L. Dawson, and T. M. Dawson (2006)
J. Biol. Chem.
281, 16193-16196
|Abstract »|Full Text »|PDF »
Metabolism of 3-nitrotyrosine induces apoptotic death in dopaminergic cells..
B. Blanchard-Fillion, D. Prou, M. Polydoro, D. Spielberg, E. Tsika, Z. Wang, S. L. Hazen, M. Koval, S. Przedborski, and H. Ischiropoulos (2006)
J. Neurosci.
26, 6124-6130
|Abstract »|Full Text »|PDF »
Neuroprotection by transgenic expression of glucose-6-phosphate dehydrogenase in dopaminergic nigrostriatal neurons of mice..
R. Mejias, J. Villadiego, C. O. Pintado, P. J. Vime, L. Gao, J. J. Toledo-Aral, M. Echevarria, and J. Lopez-Barneo (2006)
J. Neurosci.
26, 4500-4508
|Abstract »|Full Text »|PDF »
Inclusion body formation and neurodegeneration are parkin independent in a mouse model of alpha-synucleinopathy..
R. von Coelln, B. Thomas, S. A. Andrabi, K. L. Lim, J. M. Savitt, R. Saffary, W. Stirling, K. Bruno, E. J. Hess, M. K. Lee, et al. (2006)
J. Neurosci.
26, 3685-3696
|Abstract »|Full Text »|PDF »
Sodium Nitroprusside Promotes IRP2 Degradation via an Increase in Intracellular Iron and in the Absence of S Nitrosylation at C178..
J. Wang, C. Fillebeen, G. Chen, B. Andriopoulos, and K. Pantopoulos (2006)
Mol. Cell. Biol.
26, 1948-1954
|Abstract »|Full Text »|PDF »
S-nitrosothiol depletion in amyotrophic lateral sclerosis.
C. M. Schonhoff, M. Matsuoka, H. Tummala, M. A. Johnson, A. G. Estevéz, R. Wu, A.és Kamaid, K. C. Ricart, Y. Hashimoto, B. Gaston, et al. (2006)
PNAS
103, 2404-2409
|Abstract »|Full Text »|PDF »
Leucine-rich repeat kinase 2 (LRRK2) interacts with parkin, and mutant LRRK2 induces neuronal degeneration.
W. W. Smith, Z. Pei, H. Jiang, D. J. Moore, Y. Liang, A. B. West, V. L. Dawson, T. M. Dawson, and C. A. Ross (2005)
PNAS
102, 18676-18681
|Abstract »|Full Text »|PDF »
Stress-induced alterations in parkin solubility promote parkin aggregation and compromise parkin's protective function.
C. Wang, H. S. Ko, B. Thomas, F. Tsang, K. C.M. Chew, S.-P. Tay, M. W.L. Ho, T.-M. Lim, T.-W. Soong, O. Pletnikova, et al. (2005)
Hum. Mol. Genet.
14, 3885-3897
|Abstract »|Full Text »|PDF »
Nitric Oxide Regulates Transforming Growth Factor-{beta} Signaling in Endothelial Cells.
M. Saura, C. Zaragoza, B. Herranz, M. Griera, L. Diez-Marques, D. Rodriguez-Puyol, and M. Rodriguez-Puyol (2005)
Circ. Res.
97, 1115-1123
|Abstract »|Full Text »|PDF »
Protection from Alzheimer's-like disease in the mouse by genetic ablation of inducible nitric oxide synthase.
C. Nathan, N. Calingasan, J. Nezezon, A. Ding, M. S. Lucia, K. La Perle, M. Fuortes, M. Lin, S. Ehrt, N. S. Kwon, et al. (2005)
J. Exp. Med.
202, 1163-1169
|Abstract »|Full Text »|PDF »
Familial-associated mutations differentially disrupt the solubility, localization, binding and ubiquitination properties of parkin.
S. R. Sriram, X. Li, H. S. Ko, K. K.K. Chung, E. Wong, K. L. Lim, V. L. Dawson, and T. M. Dawson (2005)
Hum. Mol. Genet.
14, 2571-2586
|Abstract »|Full Text »|PDF »
Accumulation of the Authentic Parkin Substrate Aminoacyl-tRNA Synthetase Cofactor, p38/JTV-1, Leads to Catecholaminergic Cell Death.
H. S. Ko, R. von Coelln, S. R. Sriram, S. W. Kim, K. K. K. Chung, O. Pletnikova, J. Troncoso, B. Johnson, R. Saffary, E. L. Goh, et al. (2005)
J. Neurosci.
25, 7968-7978
|Abstract »|Full Text »|PDF »
Avicinylation (thioesterification): A protein modification that can regulate the response to oxidative and nitrosative stress.
V. Haridas, S.-O. Kim, G. Nishimura, A. Hausladen, J. S. Stamler, and J. U. Gutterman (2005)
PNAS
102, 10088-10093
|Abstract »|Full Text »|PDF »
Comment on "S-Nitrosylation of Parkin Regulates Ubiquitination and Compromises Parkin's Protective Function".
S. A. Lipton, T. Nakamura, D. Yao, Z.-Q. Shi, T. Uehara, and Z. Gu (2005)
Science
308, 1870b
|Full Text »|PDF »
Response to Comment on "S-Nitrosylation of Parkin Regulates Ubiquitination and Compromises Parkin's Protective Function".
K. K. K. Chung, V. L. Dawson, and T. M. Dawson (2005)
Science
308, 1870c
|Full Text »|PDF »
Increased glutathione S-transferase activity rescues dopaminergic neuron loss in a Drosophila model of Parkinson's disease.
A. J. Whitworth, D. A. Theodore, J. C. Greene, H. Benes, P. D. Wes, and L. J. Pallanck (2005)
PNAS
102, 8024-8029
|Abstract »|Full Text »|PDF »
S-Nitrosation of the Insulin Receptor, Insulin Receptor Substrate 1, and Protein Kinase B/Akt: A Novel Mechanism of Insulin Resistance.
M. A. Carvalho-Filho, M. Ueno, S. M. Hirabara, A. B. Seabra, J. B.C. Carvalheira, M. G. de Oliveira, L. A. Velloso, R. Curi, and M. J.A. Saad (2005)
Diabetes
54, 959-967
|Abstract »|Full Text »|PDF »
Genetic and genomic studies of Drosophila parkin mutants implicate oxidative stress and innate immune responses in pathogenesis.
J. C. Greene, A. J. Whitworth, L. A. Andrews, T. J. Parker, and L. J. Pallanck (2005)
Hum. Mol. Genet.
14, 799-811
|Abstract »|Full Text »|PDF »
Parkin Mediates Nonclassical, Proteasomal-Independent Ubiquitination of Synphilin-1: Implications for Lewy Body Formation.
K. L. Lim, K. C. M. Chew, J. M. M. Tan, C. Wang, K. K. K. Chung, Y. Zhang, Y. Tanaka, W. Smith, S. Engelender, C. A. Ross, et al. (2005)
J. Neurosci.
25, 2002-2009
|Abstract »|Full Text »|PDF »
Parkin Phosphorylation and Modulation of Its E3 Ubiquitin Ligase Activity.
A. Yamamoto, A. Friedlein, Y. Imai, R. Takahashi, P. J. Kahle, and C. Haass (2005)
J. Biol. Chem.
280, 3390-3399
|Abstract »|Full Text »|PDF »
Association of DJ-1 and parkin mediated by pathogenic DJ-1 mutations and oxidative stress.
D. J. Moore, L. Zhang, J. Troncoso, M. K. Lee, N. Hattori, Y. Mizuno, T. M. Dawson, and V. L. Dawson (2005)
Hum. Mol. Genet.
14, 71-84
|Abstract »|Full Text »|PDF »
Mitochondrial Injury: A Hot Spot for Parkinsonism and Parkinson's Disease?.
Nitrosative stress linked to sporadic Parkinson's disease: S-nitrosylation of parkin regulates its E3 ubiquitin ligase activity.
D. Yao, Z. Gu, T. Nakamura, Z.-Q. Shi, Y. Ma, B. Gaston, L. A. Palmer, E. M. Rockenstein, Z. Zhang, E. Masliah, et al. (2004)
PNAS
101, 10810-10814
|Abstract »|Full Text »|PDF »
S-nitrosylation: Physiological regulation of NF-{kappa}B.
H. E. Marshall, D. T. Hess, and J. S. Stamler (2004)
PNAS
101, 8841-8842
|Full Text »|PDF »